Genistein-induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study

Proteomics

Volumn 12, Issue 14, 2012, Pages 2391-2399

  Yan, Guang Rong ^a   Zou, Fei Yan ^a   Dang, Bian Li ^a   Zhang, Ye ^a   Yu, Guangchuang ^a   Liu, Xiao ^a   He, Qing Yu ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Biomedicine; Genistein; KIF20A; Kinesin; Mitotic arrest

Indexed keywords

CELL PROTEIN; GENISTEIN; KINESIN; PROTEIN CDCA8; PROTEIN CENPF; PROTEIN CIT; PROTEIN KIF11; PROTEIN KIF20A; PROTEIN KIF22; PROTEIN KIF23; PROTEIN TPX2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL VIABILITY; DOWN REGULATION; DRUG TARGETING; GENE SILENCING; MITOSIS; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SIGNAL TRANSDUCTION; STOMACH CANCER;

ANTICARCINOGENIC AGENTS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL SURVIVAL; GENE REGULATORY NETWORKS; GENISTEIN; HUMANS; KINESIN; MITOSIS; PROTEIN INTERACTION MAPS; PROTEOME; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84864556009     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100652     Document Type: Article

References (37)

1. El Touny, L. H., Banerjee, P. P., Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res. 2009, 69, 3695-3703.
2. Jamadar-Shroff, V., Papich, M. G., Suter, S. E., Soy-derived isoflavones inhibit the growth of canine lymphoid cell lines. Clin. Cancer Res. 2009, 15, 1269-1276.
3. Li, W., Frame, L. T., Hoo, K. A., Li, Y. et al., Genistein inhibited proliferation and induced apoptosis in acute lymphoblastic leukemia, lymphoma and multiple myeloma cells in vitro. Leuk. Lymphoma 2011, 52, 2380-2390.
4. Yan, G. R., Xiao, C. L., He, G. W., Yin, X. F. et al., Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways. Proteomics 2010, 10, 976-986.
5. Peterson, G., Barnes, S., Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ. 1996, 7, 1345-1351.
6. Swami, S., Krishnan, A. V., Peehl, D. M., Feldman, D., Genistein potentiates the growth inhibitory effects of 1, 25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity. Mol. Cell Endocrinol. 2005, 241, 49-61.
7. Banerjee, S., Li, Y., Wang, Z., Sarkar, F. H., Multi-targeted therapy of cancer by genistein. Cancer Lett. 2008, 269, 226-242.
8. Balashova, E. E., Dashtiev, M. I., Lokhov, P. G., Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrence. Mol. Cell Proteomics 2012, 11, M111.014480.
9. Hansen, J., Palmfeldt, J., Vang, S., Corydon, T. J. et al., Quantitative proteomics reveals cellular targets of celastrol. PLoS One 2011, 6, e26634.
10. Yan, G. R., Yin, X. F., Xiao, C. L., Tan, Z. L. et al., Identification of novel signaling components in genistein-regulated signaling pathways by quantitative phosphoproteomics. J. Proteomics 2011, 75, 695-707.
11. Yan, G. R., Xu, S. H., Tan, Z. L., Liu, L., et al., Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics. Proteomics 2011, 11, 912-920.
12. Feng, G., Du, P., Krett, N. L., Tessel, M. et al., A collection of bioconductor methods to visualize gene-list annotations. BMC Res. Notes 2010, 3, 10.
13. Yu, G., Wang, L. G., Han, Y., He, Q. Y., clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 2012, 16, 284-287.
14. Taniuchi, K., Nakagawa, H., Nakamura, T., Eguchi, H. et al., Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell. Cancer Res. 2005, 65, 105-112.
15. Snyder, P. M., Steines, J. C., Olson, D. R., Relative contribution of Nedd4 and Nedd4-2 to ENaC regulation in epithelia determined by RNA interference. J. Biol. Chem. 2004, 279, 5042-5046.
16. Gong, L., Li, Y., Nedeljkovic-Kurepa, A., Sarkar, F. H., Inactivation of NF-kappa B by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 2003, 22, 4702-4709.
17. Gadgeel, S. M., Ali, S., Philip, P. A., Wozniak, A., et al., Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines. Cancer 2009, 115, 2165-2176.
18. Li, Y., Ahmed, F., Ali, S., Philip, P. A. et al., Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res. 2005, 65, 6934-6942.
19. Huang, X. F., Luo, S. K., Xu, J., Li, J. et al., Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia. Blood 2008, 111, 2854-2865.
20. Hummer, S., Mayer, T. U., Cdk1 negatively regulates midzone localization of the mitotic kinesin Mklp2 and the chromosomal passenger complex. Curr. Biol. 2009, 19, 607-612.
21. Chu, C. S., Hsu, P. H., Lo, P. W., Scheer, E. et al., Protein kinase A-mediated serine 35 phosphorylation dissociates histone H1.4 from mitotic chromosome. J. Biol. Chem. 2011, 286, 35843-35851.
22. Kline-Smith, S. L., Walczak, C. E., Mitotic spindle assembly and chromosome segregation: refocusing on microtubule dynamics. Mol. Cell 2004, 15, 317-327.
23. Gardner, M. K., Zanic, M., Gell, C., Bormuth, V., et al., Depolymerizing kinesins Kip3 and MCAK shape cellular microtubule architecture by differential control of catastrophe. Cell 2011, 147, 1092-1103.
24. Hornick, J. E., Karanjeet, K., Collins, E. S., Hinchcliffe, E. H., Kinesins to the core: the role of microtubule-based motor proteins in building the mitotic spindle midzone. Semin. Cell Dev. Biol. 2010, 21, 290-299.
25. Takahashi, S., Fusaki, N., Ohta, S., Iwahori, Y. et al., Downregulation of KIF23 suppresses glioma proliferation. J. Neurooncol. 2012, 106, 519-529.
26. Whitehead, C. M., Rattner, J. B., Expanding the role of HsEg5 within the mitotic and post-mitotic phases of the cell cycle. J. Cell Sci. 1998, 111(Pt 17), 2551-2561.
27. Smith, E., Hegarat, N., Vesely, C., Roseboom, I. et al., Differential control of Eg5-dependent centrosome separation by Plk1 and Cdk1. Embo. J. 2011, 30, 2233-2245.
28. Maddika, S., Sy, S. M., Chen, J., Functional interaction between Chfr and Kif22 controls genomic stability. J. Biol. Chem. 2009, 284, 12998-13003.
29. Moynihan, K. L., Pooley, R., Miller, P. M., Kaverina, I., et al., Murine CENP-F regulates centrosomal microtubule nucleation and interacts with Hook2 at the centrosome. Mol. Biol. Cell 2009, 20, 4790-4803.
30. Ma, N., Tulu, U. S., Ferenz, N. P., Fagerstrom, C. et al., Poleward transport of TPX2 in the mammalian mitotic spindle requires dynein, Eg5, and microtubule flux. Mol. Biol. Cell 2010, 21, 979-988.
31. Gassmann, R., Carvalho, A., Henzing, A. J., Ruchaud, S. et al., Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J. Cell Biol. 2004, 166, 179-191.
32. Swedlow, J. R., Hirano, T., The making of the mitotic chromosome: modern insights into classical questions. Mol. Cell 2003, 11, 557-569.
33. Huszar, D., Theoclitou, M. E., Skolnik, J., Herbst, R., Kinesin motor proteins as targets for cancer therapy. Cancer Metastasis Rev. 2009, 28, 197-208.
34. Barton, V. N., Foreman, N. K., Donson, A. M., Birks, D. K. et al., Aurora kinase A as a rational target for therapy in glioblastoma. J. Neurosurg. Pediatr. 2010, 6, 98-105.
35. Daire, V., Pous, C., Kinesins and protein kinases: key players in the regulation of microtubule dynamics and organization. Arch. Biochem. Biophys. 2011, 510, 83-92.
36. Hill, E., Clarke, M., Barr, F. A., The Rab6-binding kinesin, Rab6-KIFL, is required for cytokinesis. Embo. J. 2000, 19, 5711-5719.
37. Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W. et al., Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 1999, 286, 971-974.